Opto Global is an ophthalmic innovator offering an advanced range of precision ophthalmic and optometric equipment through an extensive worldwide independent distributor network and a wholly owned North American subsidiary Opto Global, Inc., based in California. The company’s focus is to deliver early detection and treatment devices for glaucoma, cataract and AMD (Age-related Macular Degeneration), the most common causes of blindness.

Opto Global was acquired by Optos plc (LSE: OPTS) in December 2010.